Amgen Inc Investor Call Transcript | | StockXpo

Try Stockxpo Premium

Amgen Inc Investor Call Transcript

Published: Monday, January 22, 2024 · 9:28 PM  |  Updated: Monday, January 22, 2024 · 9:28 PM

📊 738 views

SHARE











Dec 05, 2022 / 01:00PM GMT
Operator

Hello, and welcome. My name is Alex, and I will be your conference facilitator today for the Amgen analyst and investor conference call from the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease Conference. (Operator Instructions) I would now like to introduce David Reese, Executive Vice President of Research and Development. Dr. Reese, you may now begin.

David M. Reese – Amgen Inc. – EVP of Research & Development

Thanks, Alex, and good morning, everyone. Thanks for joining us for an update on the AMG 133 program in obesity and allied disorders. These are review of data just presented at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.

Next slide, please. Here’s our standard safe harbor disclaimer. I did note that these slides are up on our website now for those who wish to follow along.

Next slide, please. In terms of today’s agenda, I will provide a brief introduction to our strategy in obesity and allied disorders following which Narimon, the Head of our cardiometabolic group in clini

MORE IN INSIDE INVESTMENT NEWS


Cisco AI Revenue Soars: Bullish Outlook for Networking Giant featured image

Cisco AI Revenue Soars: Bullish Outlook for Networking Giant

Published: Friday, November 13, 2026 · 9:39 AM


Nebius Shares Plunge 10%: A Warning on Cloud Capex & Outlook featured image

Nebius Shares Plunge 10%: A Warning on Cloud Capex & Outlook

Published: Thursday, November 12, 2026 · 8:27 AM

scroll to top